πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10758614

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10760048

In vitro production of medial ganglionic eminence precursor cells

The Regents of the University of California Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10736919

Materials and methods for engineering cells and uses thereof in immuno-oncology

CRISPR THERAPEUTICS AG Β· Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10729725

Materials and methods for engineering cells and uses thereof in immuno-oncology

CRISPR THERAPEUTICS AG Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10730925

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of

Protalix Ltd. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10722540

Microfluidic device and method for shear stress-induced transformation of cells

The Regents of the University of California Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10722537

Activation of resident memory T cells for cancer immunotherapy

Regents of the University of Minnesota Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10716809

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10702628

Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

Anika Therapeutics S.r.l. Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696945

Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem ce

China Medical University Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683354

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675307

Compositions comprising perivascular stem cells and nell-1 protein

The Regents of the University of California Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10675267

Methods for detection and eradication of myeloid leukemia stem cells

The Regents of the University of California Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10655103

Equine progenitor cells

University College Cardiff Consultants Limited Β· Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633451

Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633432

VC-CAR molecule and use thereof in removing HIV-1 infected cells

Shenzhen City of Regeneration Biological Pharmaceutical Technology Co., Ltd. Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633643

Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10611998

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o

The Regents of the University of California Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10596275

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to

Aura Biosciences, Inc. Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10583200

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10583202

Homologous recombination in multipotent adult progenitor cells

Regents of the University of Minnesota Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10578608

Tools to detect, track and target cancer cells in vivo

The Regents of the University of California Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568913

Method for generating mature Ξ²-like cells

Healthregen PTY LTD Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10564149

Populations of mesenchymal stem cells that secrete neurotrophic factors

BRAINSTORM CELL THERAPEUTICS LTD. Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted